Celexa
Company: Forest Laboratories
Approval Status: Approved July 1998
Treatment for: Depression
Areas: Endocrinology; Psychiatry/Psychology
| General Information | Clinical Results | Side Effects | Additional Information |
General Information
A highly selective SSRI, Celexa is the best-selling antidepressant in 13 countries, including eight in Europe.
Clinical Results
Celexa has been proven effective and well tolerated in clinical trials involving more than 23,000 Celexa-treated patients, as well as by a decade of clinical use during which more than eight million people in 64 countries have been treated with Celexa. Results from these trials show that Celexa consistently and significantly improves symptoms of depression, regardless of patient age, race or gender. In addition, studies have also shown that Celexa is significantly more effective than placebo in preventing relapse of depression.
Side Effects
Side effects reported include nausea, dry mouth and sleepiness.
Additional Information
Precautions:
As with others SSRIs, Celexa should not be taken together with
monoamine oxidase inhibitors.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
